Cargando…
Targetting an LncRNA P5848-ENO1 axis inhibits tumor growth in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) has a high recurrence rate and poor clinical outcome after currently used therapies, including radiofrequency ablation. To explore the possible mechanisms for the relapse of HCC, in the present study we focussed on long non-coding RNA (LncRNA), which has been reported...
Autores principales: | Zhu, Xidan, Yu, Hui, Li, Baolin, Quan, Jing, Zeng, Zhangrui, Li, Guangrong, Liu, Jinbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859111/ https://www.ncbi.nlm.nih.gov/pubmed/30541900 http://dx.doi.org/10.1042/BSR20180896 |
Ejemplares similares
-
Expression of Concern: Targetting an LncRNA P5848-ENO1 axis inhibits tumor growth in hepatocellular carcinoma
Publicado: (2020) -
A novel lncRNA, TCONS_00006195, represses hepatocellular carcinoma progression by inhibiting enzymatic activity of ENO1
por: Yu, Songman, et al.
Publicado: (2018) -
Inhibition of lncRNA-NEAT1 sensitizes 5-Fu resistant cervical cancer cells through de-repressing the microRNA-34a/LDHA axis
por: Shao, Xuecheng, et al.
Publicado: (2021) -
LncRNA TUG1 promotes the progression of colorectal cancer via the miR-138-5p/ZEB2 axis
por: Yan, Zhenkun, et al.
Publicado: (2020) -
PHAROH lncRNA regulates Myc translation in hepatocellular carcinoma via sequestering TIAR
por: Yu, Allen T, et al.
Publicado: (2021)